Trials Sponsors Conditions Drugs Pricing

Conditions

Diabetes Mellitus, Type 2

Keywords

FreeStyle Libre

Outcome Measures

Primary Outcomes (1)

Difference in bodyweight from the control arm at 6 months
Subjects' bodyweight will be measured during Visits 1, 3, 5 and 7. At the end of the 6 months period the bodyweight change, if any, will be assessed between the two Arms of the study.
six (6) months

Study Arms (2)

Standard of Care

No intervention will be administered. Subjects randomized to the Standard of Care Arm will continue using their Current standard of care device to monitor and manage their diabetes

Intervention

Subjects randomized to this Arm will use FreeStyle Libre 2 to monitor and manage their diabetes.

Device: FreeStyle Libre 2 Flash Glucose Monitoring System

Interventions

FreeStyle Libre 2 Flash Glucose Monitoring SystemDevice

The FreeStyle Libre 2 Flash Glucose Monitoring System is a continuous glucose monitoring (CGM) device with real time alarms capability indicated for the management of diabetes in persons age 4 and older.

Intervention

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age30 Years - 70 Years

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

Subjects who have been diagnosed with type 2 diabetes

You may qualify if:

Subject must be at least 30 years of age and no more than 70 years of age at the time of enrollment.

Sponsors & Collaborators

Abbott Diabetes Care
Industrylead

Study Sites (1)

Rainier Clinical Research Center

Renton, Washington, 98057, United States

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

Shridhara A Karinka, PhD
Abbott Diabetes Care
STUDY DIRECTOR

Enrollment

43 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: PROSPECTIVE
Sponsor Type: INDUSTRY
Responsible Party: SPONSOR

Study Record Dates

First Submitted

December 20, 2021

First Posted

December 23, 2021

Study Start

December 5, 2021

Actual (reported)

Study Stopped

T2 FSL2 Weight Loss

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Study Arms (2)

Standard of Care

Intervention

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Study Arms (2)

Standard of Care

Intervention

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations